bioRxiv / medRxiv
open access
Returning APOE and pTau-217 Results: the eSMARTER Randomized Noninferiority Clinical Trial
ImportancePatients are increasingly learning Alzheimers disease (AD) genetic and biomarker results through electronic health portals. Evaluation of alternative scalable delivery models for return of AD risk information is needed to best support patient understanding and psychological well-being. Ob
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)#890991
- Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)#870674
- An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease#915777
- A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)#873225
- Alzheimer's Disease Multiple Intervention Trial#1008264
Record · ID 1136728
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive